Public Company News

BlackLine Appoints Greg Hughes to Board of Directors, Expanding Enterprise Software and Strategic Growth Expertise

LOS ANGELES, July 29, 2025 /PRNewswire/ -- BlackLine, Inc. (Nasdaq: BL), the future-ready financial operations platform for the Office of the CFO, today announced the appointment ofGreg Hughes to its Board of Directors effective July 25, 2025. A seasoned enterprise software executive, Hughes brin...

2025-07-29 04:53 2861

NYSE Content Advisory: Pre-market update + U.S. & EU reach trade deal

NEW YORK, July 28, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-market update + U.S. & EU reach trade...

2025-07-28 20:55 3239

Big Lake Capital, LLC, Led and Controlled by NMHI CEO, Converts $671,984 Note into Nature's Miracle ("NMHI") Common Stocks

ONTARIO, Calif., July 28, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology announce that Big Lake Capital, LLC (the "Investor"), an investment company led and controlled by CEO Tie "James" Li, converted$678,29...

2025-07-28 20:30 3795

CreateAI, a Leader in Applied AI Technology, Launches Animon.ai Studio Version for Creators to Make Their Own Anime Series

Animon Studio Makes Professional Anime Creation and Storytelling Accessible to All TOKYO, July 28, 2025 /PRNewswire/ -- CreateAI Holdings ("CreateAI" or the "Company") (OTC: TSPH), a leader in applied artificial intelligence technology, today announced the launch of the Studio Version of Animon....

2025-07-28 20:00 4913

CHINA YUCHAI INTERNATIONAL TO ANNOUNCE UNAUDITED 2025 FIRST-HALF YEAR FINANCIAL RESULTS ON AUGUST 8, 2025

- Earnings Call to Begin at 8:00 A.M. EDT – SINGAPORE, July 28, 2025 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company"), announced today that it will be releasing its 2025 unaudited first-half year financial results onFriday, August 8, 2025 before t...

2025-07-28 19:45 5545

Daqo New Energy Issues Its 2024 Environmental, Social and Governance (ESG) Report

SHANGHAI, July 28, 2025 /PRNewswire/ -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy," the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today published its 2024 Environmental, Social and Governance ("ESG") report.  The 2024 ESG rep...

2025-07-28 19:00 3345

Antengene Announces XPOVIO® Approved in China for the Second-Line Treatment of Multiple Myeloma, Marking the Third Approved Indication of the Drug

- This approval for XPOVIO® in combination with bortezomib and dexamethasone (XVd) for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior therapy marks the third approved indication of the drug inChina. - XPOVIO® as a monotherapy in patients with relap...

2025-07-28 18:49 3057

OneConnect International CTO at Fortune Brainstorm AI: Future of Finance Demands Hybrid AI Approach for Trust and Control

SINGAPORE, July 28, 2025 /PRNewswire/ -- The future of artificial intelligence in finance lies in a hybrid approach that combines the generative power of large models with the precision of traditional AI to ensure trust and control, said Dr.Ming Jin, International CTO of OneConnect Financial Tech...

2025-07-28 18:41 3955

SuperX Announces Plan for the Establishment of its AI Supply Center in Japan to Accelerate End-to-End Solution Delivery

The new hub will serve as a regional center for the integration and delivery of SuperX's core AI Server and HVDC products, with a projected annual capacity of 10,000 high-performance AI servers to meet accelerating demand inJapan. SINGAPORE, July 28, 2025 /PRNewswire/ -- Super X AI Technology Lim...

2025-07-28 18:30 4756

Quhuo Partners with NIU World to Launch Innovative Fresh Beef Chain Brand Incubation Platform, Accelerating the Transformation of China's Fresh Beef Consumption Market

BEIJING, July 28, 2025 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo" or the "Company"), a leading tech-enabled service platform, today announced a strategic partnership with NIU World, a local food group inChina, to jointly establish a new chain brand incubation platform focused on fresh be...

2025-07-28 18:00 2936

Caliway Announces FDA Clearance of IND Application for CBL-514 to Proceed with SUPREME-01, the First Global Pivotal Phase 3 Study for Reducing Abdominal Subcutaneous Fat

* CBL-514, Caliway's first-in-class lipolysis drug candidate, has been granted clearance from the U.S. FDA to proceed with SUPREME-01, a global, multicenter, pivotal Phase 3 study. Subject recruitment is expected to begin in the U.S. andCanada in Q3 2025. * CBL-514 is the first 505(b)(1) inve...

2025-07-28 17:51 4048

China Literature to Report First Half 2025 Financial Results on August 12, 2025

- Earnings Conference Call to be Held on Tuesday, August 12, 2025 at 8:00 pm (Hong Kong Time) / 8:00 am (U.S. Eastern Time) HONG KONG, July 28, 2025 /PRNewswire/ -- China Literature Limited ("China Literature" or "the Company", 0772.HK), a leading online literature and intellectual property ("IP...

2025-07-28 17:39 5159

FinVolution Group Publishes Seventh Annual ESG Report

SHANGHAI, July 28, 2025 /PRNewswire/ -- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV), a leading fintech platform, today announced it has released its 2024 Environmental, Social, and Governance (ESG) report, the Company's seventh consecutive annual ESG report. The report provid...

2025-07-28 17:30 2780

Cheetah Mobile to Acquire Controlling Stake in UFACTORY to Accelerate Its Robotics Commercialization Strategy

BEIJING, July 28, 2025 /PRNewswire/ -- Cheetah Mobile Inc. (NYSE: CMCM) ("Cheetah Mobile" or the "Company"), aChina-based IT company, today announced that one of its majority-owned subsidiaries has signed a definitive agreement to acquire an equity interest of 60.8% in Shenzhen UFACTORY Technolog...

2025-07-28 17:00 3487

Doosan Robotics Accelerates Push to Become an AI Robot Solutions Leader

— Acquires 89.59% stake in U.S. automation engineering firm ONExia — Strengthens future growth engine with AI•humanoid technology•top-tier talent and builds an R&D Innovation center EXTON, Pa. and SEONGNAM, South Korea, July 28, 2025 /PRNewswire/ -- Doosan Robotics is stepping up its transformati...

2025-07-28 16:10 2486

Alteogen Receives Positive CHMP Opinion for Aflibercept Biosimilar, 'EYLUXVI® (ALT-L9)'

* CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing EYLUXVI® to the reference product Eylea® * Upon approval, EYLUXVI® will be Alteogen's second biosimilar product, following a Herceptin® biosimilar by Alteogen's license partner Qilu Pharm...

2025-07-28 14:00 3383

NMPA Accepts sNDA for Ivonescimab in Combination with Chemotherapy as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer

HONG KONG, July 28, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the National Medical Products Administration (NMPA) has accepted the supplementary New Drug Application (sNDA) for ivonescimab (PD-1/VEGF bispecific antibody) in combination with ...

2025-07-28 12:14 4008

Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025

SHANGHAI and HONG KONG, July 28, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for canc...

2025-07-28 10:40 2339

Galan Lithium Limited: Incentive Regime for HMW Project in Argentina

PERTH, Australia, July 28, 2025 /PRNewswire/ -- Galan Lithium Limited (ASX: GLN) ("Galan" or "the Company") is pleased to advise that the Comite Evaluador de Proyectos RIGI, responsible for awarding the Argentine Government's Régimen de Incentivo para Grandes Inversiones (the incentive regime for...

2025-07-28 09:00 2326

Ascletis Announces First Participants with Obesity or Overweight Dosed in Its U.S. 12-week Phase IIa Study Evaluating Once-Monthly Subcutaneous Depot Formulation of Small Molecule GLP-1R Agonist ASC30

-          First participants with obesity or overweight with at least one w eight-related comorbidity have been dosed in a U.S. 12-week Phase IIa study with once-monthly subcutaneous (SQ) depot formulation of small molecule GLP-1  receptor agonist ASC30. -          Ultra-long-acting SQ depot for...

2025-07-28 08:15 2549

Week's Top Stories